Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
People are sleeping.
Where is everyone?
No. It was done before with Harry and carried over into the business combination. How do you know it’s favorable? Look, we need to stop talking about Rosetta and giving them any attention. They need to put in a lot of work in their licensed territories and stay in them.
This is nothing new. Rosetta has had almost 2 years of using the trust license and had the product of enzoimmune out and have done nothing besides sell the product outside of their distribution area to USA citizens. Let not be quick to credit anything they have done besides to help
Themselves. Remember that. 2 years and they can’t move their product that’s been out and they can’t get anything done. They have a small small team. Valatine who’s daughter lives and goes to San Diego St at and his son who won’t leave Bulgaria and does who know what (on pro wave docs oh yeah remember that) That leaves some random guy who has no connections in his regions to distribute enzoimmune. Again, nobody gives a shit about Rosetta and what they’ve “done” hell shareholder made Rosetta give credit to Enzolytics on their website cause in the beginning they didn’t mention any of it. Any value here is in the mabs and the AI. Waiting for any Bulgarian to prove me wrong but from what we’ve seen they are in it for themselves only. Rosetta, ok.. carry on.
Did Enzc exist during the time of the patent filing. See how this is silly talk. This is why we now have a license from the zhabilov trust. Cause Enzc didn’t exist. The patent is in a trust (name) not under a company because it is his (trust) Diana the trustee (now) over sees the right to the IP and they have given those rights in the form of a license to virogentics who is a wholly owned subsidiary of Enzolytics. Let’s not over think this. Harry’s technology has been hashed out and beaten like a dead horse over and over and over. It’s not even that exciting and most are not here because of Harry and what he is bringing to the table.
Why didn’t s*aga file a extension? Oh 4 days now…
He is lol. Just cause he’s on the disclosure doesn’t mean he’s “our” friend. He’s Harry best friend with extra extra benefits. How much has he paid for the license of ipf from the trust? Why was enzoimmune selling outside his territory? I didn’t know getting a cease and desist means he’s friend lol. But go on.
I know the connection before you Mikey. My point is what his company did with the license and product of enzoimmune. His preferred shares converted. Why he got them, well Harry and his poor decision making before the business combination we are still feeling the effects. But hey, thanks for think you do everything around here. Ps step up your game and do some more research
Who cares. Rosetta had done nothing but sell enzoimmune outside of their licensed territory. I imagine Harry gave his buddy and fabulous deal. As always, Harry always gives the best deals.
Timely post …
It was on a 3rd world Bulgarian news channel that nobody saw. Yes I did see that and couldn’t help laughing the entire time and he couldn’t even explain any science cause he’s not a doctor but yet his company was licensed to do the “clinical trials”. Harry and Savov have no idea what they are doing. Harry is not a doctor he’s a chemist. Charles has had to handle Harry and his work and even bring in a consulting firm to help. They weren’t even smart enough to sign or produce a contract but Harry was quick to give away shares. This is when Harry had no idea what he was doing pre business combination Enzc. Harry is at fault. He produced this mess.
Savov sued the transfer company and also tried to (illegally) and lost in the court of law to take over Harry Zabilov previous pub co. There was never a contract produced. The “company” also wrote immb bg as a “total loss”.
Meh, like many others of said, Savov got his shares Enzc kept its IP. If, if Savov sold his shares he made around 5-6 million. Enzc IP (even itv-1) is worth more than that. What moron claims ownership without signing or could produce a legal contract in the court of law.
I’m trying to find in the patent database that Savov has any claim to itv-1 (immune therapeutic vaccine -1) only ones I’m pulling up is Zhabilov and Zhabilov trust. He’s not the inventor. I can’t find any claim that it would be “his” besides a third world country (Bulgaria) did a non ema clinical trial on test patient who (most) didn’t complete the trial that he was “licensed” even though there wasn’t a contract signed or that could be produced during some recent court documents. Savov didn’t even sign a contract? So what claim does he have? Harry gave Savov shares 71.9m for a non contracted trial. Who are these amateurs? Business in Bulgaria is what a hand shake? Good luck to Savov after he couldn’t produce any contract. I sure wouldn’t hope to be claiming I had something and was produced on official documents. I will Nika (Bulgaria horseshit) later.
That sounds interesting.
$ENZC $SAGA Enzolytics Inc (OTCMKTS: ENZC) Biotech Blue Sky Breakout (ITV-1, EME, New Products) as $250 Million Deal with SPAC Sagaliam Acquisition Corp. (NASDAQ: SAGA) Moves Forward https://newsytrends.com/2023/05/08/enzolytics-inc-otcmkts-enzc-biotech-blue-sky-breakout-itv-1-eme-new-products-as-250-million-deal-with-spac-sagaliam-acquisition-corp-nasdaq-saga-moves-forward/
Why is IPF Immune on Walmart site now? Geez this was never supposed to happen.
This has nothing to do Enzolytics. Remember Charles was a patent attorney before he was the CEO. No need to go down a rabbit hole that doesn’t end with getting a carrot.
Non sec reporting pr’s are not going to do anything. Repeat that over and over. 8k’s and larger entity Pharma companies mentioning is in their sec reporting pr’s will do something. We havnt ever “moved” cause we’ve yet to have these things happen. This has never ever moved. I don’t consider the move to 95 cents a move cause it was never backed up by any “reporting” agency. And of course the fall back down. Again, this won’t ever move, with non sec reporting.
You have way to high expectations. Bless you.
Life of a biotech company. This shouldn’t be a surprise (timelines) it takes a long. There are delays and bumps in the road. Imagine doing this inside of a global pandemic.
I didn’t know filing a patent application for the feline leukemia virus and discovering 26 immutable sites was old news. I didn’t know not only the patent application covers the production is mabs but also a vaccine and diagnostic testing to detect the virus. I have a lot of catching up to do.
This has the same corp address as cehd. The email listed on the otc page is also close to shadi bakir company Bicorp technologies Ltd. Interesting cause Messaben (cehd) has them listed as a partner on their website. I wonder if this is a RM of Bicorp technologies.
This looks like a RM. Rami Bakir is listed on the otc page and he is the ceo of a company called Massaben. The timing also matches up. Messaben is a company out of Spain but looks like they are doing business out of Dubai and makes sense with what Messaben does. I also noticed a company called InFocus that has the same listed address and phone number as Messaben. Looks like Infocus is out of Canada but has a office with Messaben. Will be interesting to see how this develops.
Jeff for the win!
Where the bears at lol https://www.the-yuan.com/177/Demystifying-the-Human-Microbiome-Using-AI.html
They’re not trying to be a pharmaceutical company. People get this confused all the time. They are a drug development company. Big difference.
Correct. If we knew who would be paying for clinicals for clone 3 well… we wouldn’t be where we are now (pps) that’s for sure. I have my thoughts who is interested but nobody cares about that. I believe we are milestone driven company. But it’s nearly impossible to put clone 3 through everything without a partner. In the meantime we have mabs for animals who management have said “several companies” are interested in. This again will be us licensing out to them and they take over. regulatory process is far less stringent and much quicker to market. Q4 2022 as Chandra said in the last interview with Hicks.
Wait people don’t know about this? From Bioclonetics website. Why do you think they are confident? Well..
In Dr. Fauci's primate phage-display peptide vaccine studies, primates were vaccinated with a peptide immunogen represented as the linear KLVC rather than KLIC. (Fauci et al., Nature Medicine, Volume 7, Number 11, November 2001, pp. 1225-1231). KLVC is a linear peptide having a conservative amino-acid substitution of valine (V) for isoleucine (I). KLIC occurs in the native HIV-1 gp41 amino acid sequence and is essentially seen as the same immunogen.
The vaccinated primates produced an antibody [anti-KLVC] that is cross-reactive with linear peptide KLIC?an amino acid sequence on HIV gp41 (and SHIV gp41). When the primates were challenged with the SHIV virus [having the gp41 amino acid sequence KLIC], the vaccinated primates'although infected with SHIV were infected at a lower SHIV viral set point than the SHIV challenged non-vaccinated control primate. Moreover, the vaccinated primates retained normal T4 cell counts while the non-vaccinated control primate's T4 cell counts decreased and progressed to AIDS and death within 6 months of SHIV challenge. The KLVC vaccinated primates' health status were that of a Long-Term Non-Progressor (LTNP).
If they have to. That’s worst case cause there is no other options at that point. But that’s not their intentions at all. If the data is good there is no need fear monger. Only thing that matters is the data. So we shouldn’t be even talking about trying to go alone into clinicals and trails. It’s silly to even bring up.
Mabs work right now? (HIV) you realize one of the most popular mabs used in Prep you have to take a pill every single day. Effective treatment that bioclonetics/Enzolytics states is at a minimum their mabs you would only need treatment once a year. That is insane. Of course this is unheard of. Now, no treatment HTLV 1/2. I thought we were behind? What if we’re the first company to provide an effective treatment for that? Go down the list. 17 infectious diseases. Now do animals. I can’t even really get into it cause it’s to long to describe.
What people fail to understand is Enzolytics is NOT taking the drug through clinicals. Just like itv-1 IMPL is paying for the clinical/trails the same will be done for Clone 3. They are a drug development company. They have always said they do not intend to go to trails alone. They will license it’s out and they (Pharma) will take over.
Agree for the most part. Itv-1 value is specifically immunotherapy used in conjunction with a main drug. If they can combine itv-1 and clone3 like they have said they are planning to do it will be extremely unique. But as you said itv-1 alone as a adjuvant is just that. Now, a patient can choose just itv-1 (when approved) as a therapy and the cost would be greatly lower than clone 3. Obviously the crown jewel in this is clone 3 but I believe there are factors when it comes to treatment.
What?? You never said gimmicks. Hahahah
This was less than a month ago. Lol gimmicks is the wording.
Glad we cleared up the patent for the immune modulator. Some of you on here look funny. So many false, and misleading statements. That’s im*b! Lol. That’s Harry’s patents and not Enzolytics and he will be only making money not the company! Lol. That has nothing to with US! Lol. Some people on here really don’t know how to add 2+2. A lot don’t do any DD. Remember. Oh what will be next? I’m sure something to spread FUD. But hey guess what Enzolytics will have a Immune Modulator! Careful who you listen to on here.
It’s right on the website: (enzoimmune)
24 months from production date. Store in dark place, away from sunlight, at room temperature. Keep away from children. Manufactured: in EU under license of Zhabilov Trust, USA for Rosetta Lifecare Bulgaria LTD, 8b Bialo Pole Str, 1618 Sofia, Bulgaria, tel: + 359 89 444 03 60, email: rosettabg@abv.bg.
Where was the confusion in the first place? This website has been around since July of last year. For everyone to see. And we are STILL going over this.
Who owns that patent? The Zhabilov trust. Who is the trustee of the patent? Diana Zhabilov. Who is a COMPANY INSIDER listed on the OTC page. Diana Zhabilov. Please stop. It’s all listed. You have to simply put 2 and 2 together. I’ll go one step further who the director of Virogentics? Diana Zhabilov. Who is Virogentics? They are a Wholly own subsidiary of Enzolytics.
This is about to get a interesting. Savov served. Finally. Has Savov been in contact with certain people maybe even other shareholders to cause harm to shareholder value? Tea drink.